API und Ausgangsarzneistoff
Vancomycin
CAS 1404-90-6 · C66H75Cl2N9O24 · 15 Verunreinigungen und verwandte Verbindungen
01API und Ausgangsarzneistoff
2D structurePubChem CID 14969

| CAS RN | 1404-90-6 |
|---|---|
| PubChem CID | 14969 |
| Molecular formula | C66H75Cl2N9O24 |
| IUPAC name | (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid |
| Defined stereocentres | 18 |
| Unassigned stereocentres | 0 |
02Strukturelles Nitrosamin-Screening
Structure-only screen. Manufacturing conditions, nitrite sources, pH, temperature and purge controls require a separate process assessment.
03Status in Indien
Exact-compound comparison only. Confirm the current official instrument before making a regulatory decision.
05Quellen
- S01




![Two-dimensional chemical structure of [L-ß-Asp3] Vancomycin B (CDP-1 minor)/ Vancomycin EP Impurity E/ Vancomycin Impurity B1, CAS 55598-85-1](/structures/pubchem/180517-300.png)






![Two-dimensional chemical structure of Vancomycin EP Impurity F/ (RS3) [L-α-Gln3]Vancomycin B, CAS 2415254-43-0](/structures/pubchem/101653007-300.png)



